<DOC>
	<DOCNO>NCT00365339</DOCNO>
	<brief_summary>The purpose clinical research study ass pharmacokinetics atazanavir , identify one dosing regimens atazanavir/ritonavir/tenofovir dose famotidine result atazanavir exposure similar atazanavir/ritonavir/tenofovir 300/100/300 mg dose without famotidine healthy subject .</brief_summary>
	<brief_title>Drug Interaction Study With Famotidine , Atazanavir , Atazanavir/Ritonavir/Tenofovir</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Healthy male female subject age 18 50 year old BMI 18 32 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>HIV</keyword>
	<keyword>Protease Inhibitor</keyword>
</DOC>